International regulation: the importance of quality assurance in drug development
European Pharmaceutical Review
JULY 4, 2023
Since the first ADC was approved by the EMA in 2012, they have generated a great deal of interest in the oncology field because of their potential to address many of the challenges of traditional chemotherapy options. Teams must also accept the variety of analytical procedures these regulatory agencies prefer.
84 
Let's personalize your content